Advances in single-cell transcriptomic sequencing in hepatic echinococcosis
-
By
-
Yi-bin Xie
-
Chun-xiu He
-
Qin-dong Jing
-
Rui-long Ma
-
Yu-qiang Tang
-
Lin-xun Liu
-
Ji-de A
-
Qing-long Tan
-
July 13, 2026
Clinical Scorecard: Recent Developments in Single-Cell Transcriptomic Analysis for Hepatic Echinococcosis
At a Glance
| Category | Detail |
|---|
| Condition | Hepatic Echinococcosis |
| Key Mechanisms | Infection by Echinococcus tapeworms, immune response, and cellular heterogeneity. |
| Target Population | Residents in endemic areas affected by Echinococcosis. |
| Care Setting | Clinical research utilizing high-throughput sequencing technology. |
Key Highlights
- Hepatic Echinococcosis is classified into hepatic alveolar and cystic forms.
- Single-cell RNA sequencing (ScRNA-seq) provides insights into immune cell dynamics.
- Echinococcosis poses significant health risks, including organ dysfunction and potential mortality.
Guideline-Based Recommendations
Diagnosis
- Utilize single-cell transcriptomic analysis for understanding molecular immunopathogenesis.
Management
- Surgical treatment combined with benzimidazole medication is the main therapy.
Monitoring & Follow-up
- Monitor the immune microenvironment and cellular interactions in lesions.
Risks
- Rupture of cysts can lead to allergic reactions and impaired organ function.
Patient & Prescribing Data
Individuals with hepatic Echinococcosis in endemic regions.
Limited chemotherapeutic options necessitate exploration of new therapeutic targets.
Clinical Best Practices
- Integrate high-throughput sequencing in clinical research for better understanding of Echinococcosis.
- Focus on the heterogeneity of infiltrating immune cells in treatment strategies.
Related Resources & Content
